Rothschild Investment LLC’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.19K Sell
33
-38
-54% -$3.22K ﹤0.01% 2718
2026
Q1
$7.06K Buy
71
+5
+8% +$652 ﹤0.01% 1879
2025
Q4
$8.03K Buy
66
+1
+2% +$125 ﹤0.01% 1664
2025
Q3
$7.29K Sell
65
-17
-21% -$1.99K ﹤0.01% 1558
2025
Q2
$11K Buy
82
+15
+22% +$1.65K ﹤0.01% 1188
2025
Q1
$4.51K Buy
67
+30
+81% +$2.06K ﹤0.01% 1486
2024
Q4
$2.31K Buy
37
+5
+16% +$465 ﹤0.01% 1723
2024
Q3
$5.02K Buy
32
+13
+68% +$2K ﹤0.01% 1290
2024
Q2
$2.86K Buy
19
+14
+280% +$1.68K ﹤0.01% 1296
2024
Q1
$370 Buy
+5
New +$412 ﹤0.01% 1470

Other funds holding TMDX

Rothschild Investment LLC's TMDX Position: Q2 2026 in Review

Rothschild Investment LLC reduced its Transmedics (TMDX) stake by 54% in Q2 2026, selling an estimated $3.22K and leaving 33 shares worth $2.19K. The position accounts for ﹤0.01% of the portfolio, ranked #2718.

Rothschild Investment LLC first reported a position in TMDX in Q1 2024 and has held it in 10 quarters since. The position peaked at $11K in Q2 2025. 354 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Rothschild Investment LLC held 33 shares of Transmedics worth $2.19K as of Q2 2026.
  • Rothschild Investment LLC sold 38 Transmedics shares in Q2 2026, an estimated $3.22K.
  • Transmedics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2718 holding.
  • Rothschild Investment LLC first reported a position in Transmedics in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's Transmedics position peaked at $11K in Q2 2025.
  • 354 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.